Patent Assignment
Reel/Frame 057059/0802
Change of Name
Recorded: 2021-08-02
Pages: 9
Assignor
NANTKWEST, INC.
Executed: 2021-03-09
Assignee
IMMUNITYBIO, INC.
3530 JOHN HOPKINS COURT, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(30)
Natural killer cell lines and methods of use
Interleukin-Secreting Natural Killer Cell Lines and Methods of Use
Tumoricidal and Antimicrobial Compositions and Methods
Genetically Modified Nk-92 Cells and Monoclonal Antibodies for the Treatment of Cancer
MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
Tumoricidal and Antimicrobial Compositions and Methods
Tumoricidal and Antimicrobial Compositions and Methods
A Tumoricidal and Antimicrobial Composition
Tumoricidal and Antimicrobial Compositions and Methods
Hla Class I-Deficient Nk-92 Cells with Decreased Immunogenicity
Application:
16/337,996 →
Publication:
US 2019/0233797
MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
Genetically Modified Nk-92 Cells with Decreased CD96/Tigit Expression
Application:
16/475,926 →
Publication:
US 2020/0123503
Genetically Modified Nk-92 Cells and Monoclonal Antiboides for the Treatment of Cancer
Tumoricidal and Antimicrobial Compositions and Methods
Anti-Egfr/High Affinity Nk-Cells Compositions and Methods for Chordoma Treatment
Application:
16/604,341 →
Publication:
US 2020/0155599
Nk-92 Cells and Il-15 Agonist Combination Therapy
Application:
16/620,791 →
Publication:
US 2020/0121720
Methods for Treating Merkel Cell Carcinoma (Mcc) Using Nk-92 Cells
Application:
16/620,855 →
Publication:
US 2020/0171087
NK-92 Cells to Stimulate Anti-Cancer Vaccine
Application:
16/760,893 →
Publication:
US 2021/0187024
Genetically Modified Nk-92 Cells and Monoclonal Antiboides for the Treatment of Cancer
MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
Use of 5% Human Albumin in Wash and Harvest Media
Application:
16/964,962 →
Publication:
US 2021/0040451
Methods and Systems for Cell Bed Formation During Bioprocessing
Optimization of Nk-92 Cell Growth Using Poloxamer
Application:
17/057,494 →
Publication:
US 2021/0363484
Generating Cik Nkt Cells from Cord Blood
Genetically Modified Nk-92 Cells and Monoclonal Antibodies for the Treatment of Cancer
Generating Cik Nkt Cells from Cord Blood
Application:
17/260,544 →
Publication:
US 2022/0133789
Cryopreservation
Application:
17/260,545 →
Publication:
US 2021/0267190
Combined Invasion and Cytotoxicity Assay Using Chemokine Secreting Target Cells
Chemokine Responsive Activated Natural Killer Cells with Secondary Homing Activation for Verified Targets
Il-2 Dependent Nk-92 Cells with Stable Fc Receptor Expression
Application:
17/295,010 →
Publication:
US 2022/0017594
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 8, 2009
From: KLINGEMANN, HANS
To: ZELLERX CORPORATION
Reel/Frame 022790/0964 →
Security Agreement
Oct 6, 2009
From: ZELLERX CORPORATION
To: MOSKOVITS, DAVID; SCHLESINGER, MICHAEL; ANDREW SCHLESINGER DEFINED BENEFIT PLAN; SPREI, ELI INZLICHT
Reel/Frame 023332/0107 →
Change of Name
Jun 2, 2011
From: ZELLERX CORPORATION
To: CONKWEST, INC.
Reel/Frame 026382/0184 →
Change of Name
Mar 11, 2016
From: CONKWEST, INC.
To: NANTKWEST, INC.
Reel/Frame 038071/0681 →
Assignment of Assignor's Interest
Jun 15, 2016
From: KLINGEMANN, HANS G.; SIMON, BARRY J
To: NANTKWEST, INC.
Reel/Frame 038917/0794 →
Change of Name
Sep 23, 2018
From: CONKWEST, INC.
To: NANTKWEST, INC.
Reel/Frame 047129/0204 →
Assignment of Assignor's Interest
Jan 9, 2019
From: LEE, TIEN; KLINGEMANN, HANS G.; SIMON, BARRY J.; BOISSEL, LAURENT
To: NANTKWEST, INC.
Reel/Frame 047946/0273 →
Assignment of Assignor's Interest
Jan 17, 2019
From: KLINGEMANN, HANS G.; SIMON, BARRY J.
To: NANTKWEST, INC.
Reel/Frame 048049/0269 →
Assignment of Assignor's Interest
Apr 22, 2019
From: NAVARRO, FRANCISCO; KLINGEMANN, HANS
To: NANTKWEST, INC.
Reel/Frame 048955/0177 →
Assignment of Assignor's Interest
May 21, 2019
From: KLINGEMANN, HANS; BOISSEL, LAURENT; SOON-SHIONG, PATRICK
To: NANTKWEST, INC.
Reel/Frame 049247/0421 →
Assignment of Assignor's Interest
Jun 24, 2019
From: KLINGEMANN, HANS; BOISSEL, LAURENT; SOON-SHIONG, PATRICK
To: NANTKWEST, INC.
Reel/Frame 049571/0871 →
Assignment of Assignor's Interest
Sep 10, 2019
From: KLINGEMANN, HANS G.; SIMON, BARRY J.
To: NANTKWEST, INC.
Reel/Frame 050332/0607 →
Assignment of Assignor's Interest
Sep 12, 2019
From: LEE, TIEN; KLINGEMANN, HANS G.; SIMON, BARRY J.; BOISSEL, LAURENT
To: NANTKWEST, INC.
Reel/Frame 050362/0401 →
Assignment of Assignor's Interest
Apr 17, 2020
From: KLINGEMANN, HANS; LEE, TIEN; BOISSEL, LAURENT
To: NANTKWEST, INC.
Reel/Frame 052431/0986 →
Assignment of Assignor's Interest
Apr 17, 2020
From: KLINGEMANN, HANS; LEE, TIEN; BOISSEL, LAURENT
To: NANTKWEST, INC.
Reel/Frame 052431/0742 →
Assignment of Assignor's Interest
Jun 15, 2020
From: KLINGEMANN, HANS G.; BOISSEL, LAURENT H.; SCHOMER, NATHAN
To: NANTKWEST, INC.
Reel/Frame 052943/0655 →
Assignment of Assignor's Interest
Jun 30, 2020
From: KLINGEMANN, HANS G.; SIMON, BARRY J.
To: NANTKWEST, INC.
Reel/Frame 053093/0414 →
Assignment of Assignor's Interest
Jun 30, 2020
From: LEE, TIEN; KLINGEMANN, HANS G.; SIMON, BARRY J.; BOISSEL, LAURENT
To: NANTKWEST, INC.
Reel/Frame 053088/0467 →
Release of Security Interest
Jul 23, 2021
From: CONKWEST, INC.
To: WEISS, ANNIE; DAYAN, RAYMOND; BUXBAUM, GARY; LOWEY, ELIOT
Reel/Frame 056970/0001 →
Assignment of Assignor's Interest
Oct 23, 2023
From: CAMPBELL, KERRY
To: INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER
Reel/Frame 065304/0975 →
Security Interest
Jan 2, 2024
From: IMMUNITYBIO, INC.; NANTCELL, INC.; RECEPTOME, INC.; VBC HOLDINGS LLC
To: INFINITY SA LLC, AS PURCHASER AGENT
Reel/Frame 066179/0074 →